Pryymachuk, Galyna http://orcid.org/0000-0002-6971-2802
El-Awaad, Ehab http://orcid.org/0000-0003-3383-6384
Piekarek, Nadin http://orcid.org/0000-0002-2954-0145
Drebber, Uta http://orcid.org/0000-0002-2697-4685
Maul, Alexandra C. http://orcid.org/0000-0003-0621-0968
Hescheler, Juergen http://orcid.org/0000-0001-7686-6562
Wodarz, Andreas http://orcid.org/0000-0002-0007-6289
Pfitzer, Gabriele http://orcid.org/0000-0002-8684-8947
Neiss, Wolfram F. http://orcid.org/0000-0002-5035-5825
Pietsch, Markus http://orcid.org/0000-0002-8110-2265
Schroeter, Mechthild M. http://orcid.org/0000-0003-0184-1146
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (INST 1856/66-1 FUGG)
German Academic Exchange Service-German Egyptian Research Long-Term scholarship (A/12/93239, 91541390)
Rottendorf foundation
Graduate Program in Pharmacology and Experimental Therapeutics of the University of Cologne and Bayer Healthcare (N14, N14)
Universitätsklinikum Köln
Article History
Accepted: 7 February 2022
First Online: 28 February 2022
Declarations
:
: The authors have no conflicts of interest to declare that are relevant to the content of this article.
: The study was approved by the ethics committee of the University Hospital of Cologne (18-052).
: Written informed consent was obtained from all subjects before sample collection.
: Not applicable.